Literature DB >> 11023142

What degree of maternal metabolic control in women with type 1 diabetes is associated with normal body size and proportions in full-term infants?

G Mello1, E Parretti, F Mecacci, P La Torre, R Cioni, D Cianciulli, G Scarselli.   

Abstract

OBJECTIVE: To assess what degree of maternal metabolic control in women with type 1 diabetes is associated with normal fetal growth and results in normal neonatal body proportions in a group of full-term infants. RESEARCH DESIGN AND METHODS: We investigated the anthropometric characteristics of 98 full-term singleton infants born to 98 Caucasian women with type 1 diabetes enrolled within 12 weeks of gestation. The type 1 diabetic mother-infant pairs were divided into three groups on the basis of the daily glucose levels reached during the second and third trimesters of pregnancy (group 1: 37 mother-infant pairs with an average daily glucose level during the second and third trimesters of < or =95 mg/dl; group 2: 37 mother-infant pairs with an average daily glucose level during the second trimester of >95 mg/dl and during the third trimester of < or =95 mg/dl; group 3: 24 mother-infant pairs with an average daily glucose level during the second and third trimesters of >95 mg/dl; control group: 1,415 Caucasian mother-infant pairs with full-term singleton pregnancies and normal glucose challenge test screened for gestational diabetes.
RESULTS: Infants of diabetic mothers in group 1 were similar to those of the control group in birth weight and in other anthropometric parameters. In contrast, offspring of diabetic mothers of groups 2 and 3 showed an increased incidence of large-for-gestational-age infants, significantly greater means of ponderal index and thoracic circumferences, and significantly smaller cranial/thoracic circumference ratios with respect to the control group.
CONCLUSIONS: The results of our study suggest that, in diabetic pregnancies, only overall daily glucose values < or =95 mg/dl throughout the second and third trimesters can avoid alterations in fetal growth.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023142     DOI: 10.2337/diacare.23.10.1494

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  14 in total

Review 1.  Glycemic targets in pregnancies affected by diabetes: historical perspective and future directions.

Authors:  Teri L Hernandez
Journal:  Curr Diab Rep       Date:  2015-01       Impact factor: 4.810

2.  Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care.

Authors:  John L Kitzmiller; Jennifer M Block; Florence M Brown; Patrick M Catalano; Deborah L Conway; Donald R Coustan; Erica P Gunderson; William H Herman; Lisa D Hoffman; Maribeth Inturrisi; Lois B Jovanovic; Siri I Kjos; Robert H Knopp; Martin N Montoro; Edward S Ogata; Pathmaja Paramsothy; Diane M Reader; Barak M Rosenn; Alyce M Thomas; M Sue Kirkman
Journal:  Diabetes Care       Date:  2008-05       Impact factor: 19.112

3.  HbA(1c) and birthweight in women with pre-conception type 1 and type 2 diabetes: a population-based cohort study.

Authors:  S V Glinianaia; P W G Tennant; R W Bilous; J Rankin; R Bell
Journal:  Diabetologia       Date:  2012-09-27       Impact factor: 10.122

Review 4.  Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.

Authors:  Foong Ming Moy; Amita Ray; Brian S Buckley; Helen M West
Journal:  Cochrane Database Syst Rev       Date:  2017-06-11

5.  Fetal growth is increased by maternal type 1 diabetes and HLA DR4-related gene interactions.

Authors:  M Hummel; S Marienfeld; M Huppmann; A Knopff; M Voigt; E Bonifacio; A-G Ziegler
Journal:  Diabetologia       Date:  2007-02-20       Impact factor: 10.122

6.  Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.

Authors:  Leanne V Jones; Amita Ray; Foong Ming Moy; Brian S Buckley
Journal:  Cochrane Database Syst Rev       Date:  2019-05-23

7.  Insulin glargine safety in pregnancy: a transplacental transfer study.

Authors:  Erika K Pollex; Denice S Feig; Angelika Lubetsky; Paul M Yip; Gideon Koren
Journal:  Diabetes Care       Date:  2009-10-06       Impact factor: 19.112

8.  Adverse pregnancy outcomes in women with diabetes.

Authors:  Carlos Antonio Negrato; Rosiane Mattar; Marilia B Gomes
Journal:  Diabetol Metab Syndr       Date:  2012-09-11       Impact factor: 3.320

9.  Predictors of overweight during childhood in offspring of parents with type 1 diabetes.

Authors:  Sandra Hummel; Maren Pflüger; Susanne Kreichauf; Michael Hummel; Anette-G Ziegler
Journal:  Diabetes Care       Date:  2009-02-19       Impact factor: 17.152

10.  Poor pregnancy outcome in women with type 1 diabetes is predicted by elevated HbA1c and spikes of high glucose values in the third trimester.

Authors:  Peter Damm; Henriette Mersebach; Jacob Råstam; Risto Kaaja; Moshe Hod; David R McCance; Elisabeth R Mathiesen
Journal:  J Matern Fetal Neonatal Med       Date:  2013-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.